Assembly Biosciences Inc — 貸借対照表 (NASDAQ:ASMB) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 283.25 M191.06 M101.79 M136.82 M119.17 M257.59 M 負債合計 42.68 M22.13 M19.13 M95.73 M85.81 M50.84 M 純資産合計 240.58 M168.93 M82.66 M41.1 M33.36 M206.75 M 負債および純資産合計 283.25 M191.06 M101.79 M136.82 M119.17 M257.59 M 有利子負債合計 —————— 純負債 ——————

ニュース

Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

ジェフリーズ、アセンブリー・バイオサイエンシズの目標株価をHSVデータを受け62ドルに引き上げ

Jefferies raises Assembly Biosciences stock price target to $62 on HSV data

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies - Slideshow (NASDAQ:ASMB) 2025-12-08